Novel integrative genomic tool for interrogating lithium response in bipolar disorder
J G Hunsberger1, F L Chibane1, A G Elkahloun2
1Molecular Neurobiology Section, National Institute of Mental Health (NIMH), National Institutes of Health, Bethesda, MD, USA.
Translational Psychiatry
|February 4, 2015
Summary
We created GRANITE, an open-source tool for analyzing genomic data to generate interactive networks. This tool identified the Let-7 miRNA family as downregulated by lithium in bipolar disorder cells, offering insights into treatment response.
Area of Science:
- Genomics
- Bioinformatics
- Systems Biology
Background:
- Bipolar disorder (BD) is a severe mood disorder with complex treatment responses.
- Lithium (Li) is an effective BD treatment, but its mechanism and non-response are not fully understood.
- Analyzing gene expression data can reveal insights into treatment efficacy.
Purpose of the Study:
- To introduce GRANITE (Genetic Regulatory Analysis of Networks Investigational Tool Environment), a novel open-source tool for analyzing complex genomic data.
- To demonstrate GRANITE's capability in generating interactive networks from gene expression profiles.
- To investigate lithium response in bipolar disorder using GRANITE.
Main Methods:
- Developed GRANITE, an integrative genomic analysis tool for creating interactive networks.
- Performed in vitro study comparing vehicle vs. chronic lithium treatment in patient-derived lymphoblastoid cells (LCLs) from lithium responders and non-responders.
- Utilized microRNA (miRNA) and messenger RNA (mRNA) gene expression profiling.
Main Results:
- GRANITE successfully generated interactive network visualizations for lithium responders and non-responders in BD.
- The Let-7 miRNA family was consistently downregulated by lithium treatment in both patient groups.
- The Let-7 family is implicated in neurodegeneration, cell survival, and synaptic development.
Conclusions:
- GRANITE is a valuable open-source tool for genomic data analysis and network generation.
- Lithium's downregulation of the Let-7 miRNA family may contribute to its therapeutic effects in bipolar disorder.
- This approach holds potential for predicting treatment response and identifying novel drug targets.
Related Concept Videos
Mania and Antimanic Drugs: Overview
802
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
802
Bipolar Disorder
1.5K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.5K
Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Pharmacogenomics: Identification of New Drug Targets
98
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98


